UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934

         Date of Report (date of earliest event reported): May 10, 2005


                            HEALTHSOUTH Corporation
             (Exact Name of Registrant as Specified in its Charter)

                                    Delaware
                 (State or Other Jurisdiction of Incorporation)

              1-10315                                  63-0860407
      (Commission File Number)              (IRS Employer Identification No.)


               One HEALTHSOUTH Parkway, Birmingham, Alabama 35243
          ------------------------------------------------------------
          (Address of Principal Executive Offices, Including Zip Code)


                                 (205) 967-7116
                                 --------------
              (Registrant's Telephone Number, Including Area Code)


Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

[ ]   Written communications pursuant to Rule 425 under the Securities Act
      (17 CFR 230.425)

[ ]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
      CFR 240.14a-12)

[ ]   Pre-commencement communications pursuant to Rule 14d-2(b) under the
      Exchange Act (17 CFR 240.14d-2(b))

[ ]   Pre-commencement communications pursuant to Rule 13e-4(c) under the
      Exchange Act (17 CFR 240.13e-4(c))

<PAGE>

ITEM 1.01   Entry into a Material Definitive Agreement

         As previously reported in its Current Report on Form 8-K filed with
the Securities and Exchange Commission on April 18, 2005, Joel C. Gordon
resigned, effective May 10, 2005, from the Board of Directors of HEALTHSOUTH
Corporation (the "Company"), where he served as Chairman Emeritus.

         In connection with Mr. Gordon's resignation, the Company entered into
a letter agreement with Mr. Gordon dated as of May 10, 2005 (the "Agreement"),
regarding certain matters relating to Mr. Gordon's retirement. The Agreement,
among other things, (a) acknowledges that Mr. Gordon's current indemnity
agreement remains in full force and effect following his resignation, (b) sets
forth the effect of Mr. Gordon's resignation on his outstanding stock options
and restricted stock grants and (c) provides that the Company will furnish
information to Mr. Gordon with respect to certain actions, suits, proceedings
or investigations involving the Company or any of its present or former
directors and that Mr. Gordon will cooperate in good faith with all reasonable
requests by the Company in connection with such actions, suits, proceedings or
investigations.

         The description of the Agreement contained herein is qualified in its
entirety by reference to the Agreement, a copy of which is attached hereto as
Exhibit 10 and incorporated herein by reference.

ITEM 9.01.  Financial Statements and Exhibits.

(c) Exhibits.

See Exhibit Index.

<PAGE>

                                   SIGNATURES


         Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Current Report on Form 8-K to be signed on
its behalf by the undersigned hereunto duly authorized.

                                      HEALTHSOUTH CORPORATION


                                      By: /s/ Gregory L. Doody
                                         ------------------------------------
                                          Name:  Gregory L. Doody
                                          Title: Executive Vice President,
                                                 General Counsel and Secretary


Dated:  May 10, 2005

<PAGE>




                                 EXHIBIT INDEX


  Exhibit Number          Description
  --------------          -----------

      10                  Letter Agreement dated as of May 10, 2005, between
                          HEALTHSOUTH Corporation and Joel C. Gordon.

<PAGE>

                                                                    EXHIBIT 10

                           LETTERHEAD OF HEALTHSOUTH

                                  May 10, 2005


Joel C. Gordon
The Gordon Group
Suite 650
3102 West End Avenue
Nashville, TN  37203

Dear Joel:

         This is to confirm our agreement with respect to the matters set forth
below, all of which have been agreed to in connection with your retirement from
the Board of Directors of HealthSouth Corporation (the "Company").

     1.   Indemnity Agreement. Reference is made to that certain Indemnity
          Agreement ("Indemnity Agreement"), dated as of March 27, 2003, by and
          between you ("Director") and the Company. The Company hereby
          acknowledges, reaffirms and agrees that the Indemnity Agreement is
          and will continue to be in full force and effect, enforceable in
          accordance with the terms thereof, including after Director ceases to
          be a member of the Company's Board of Directors.

     2.   Equity Awards. Reference is made to that certain memorandum to Jay
          Grinney from Gregory L. Doody dated March 10, 2005 (the "Memorandum")
          regarding the effect of Director's retirement from the Board on the
          equity awards previously granted to Director by the Company. The
          Company hereby agrees that as set forth in the Memorandum by virtue
          of Director's retirement

          a.   all currently outstanding stock options (relating to 300,000
               shares with varying strike prices) would terminate within three
               months of Director's retirement in the event that they remain
               unexercised;

          b.   the restricted stock granted to Director on January 1, 2005
               (7,962 shares) would be forfeited; and

          c.   the remaining forfeiture provisions applicable to restricted
               stock granted to Director on January 20, 2004 and March 1, 2005
               shares (totaling 34,702 shares) would lapse.

     3.   Access to Information. The Company hereby agrees that, subject to
          appropriate confidentiality undertakings by Director, applicable
          attorney-client and other applicable privileges and to the extent not
          otherwise precluded by applicable law or contrary to a request of
          governmental authorities, at the request from time to time by
          Director or Director's authorized representative, the Company shall,
          and shall cause its General Counsel or his designees (or, if there is
          no General Counsel, by its Chief Financial Officer or his designees)
          to, furnish to Director or Director's authorized representatives
          updates and other requested information with respect to any actions,
          suits, or proceedings against, or any governmental investigations or
          negotiations with third parties involving, the Company or any of its
          present or former members of the Board of Directors, in each case
          only to the extent that such matter (i) arises from facts that took
          place prior to the date on which Director ceases to be a director of
          the Company and (ii) reasonably relates to the interests of Director
          (collectively, "Actions"). To the extent that any such requested
          information constitutes legal advice or other information subject to
          the attorney-client or related privilege, the Company shall provide
          such information to Director, so long as such information will
          continue to be subject to the attorney-client or other privilege (it
          being understood that the Company will enter into joint defense or
          other arrangements to protect the status of such information as
          privileged, if such arrangement would be effective to provide such
          protection), unless, (i) such information addresses a matter as to
          which the parties have a conflict of interests, or (ii) the Company
          has reasonably determined that providing such information will be
          materially prejudicial to the Company; provided that the immediately
          preceding clause (ii) shall not be a basis for denial of any Director
          request for privileged information if such information refers to
          Director or reflects Director's conduct or statements and, in such
          case, such information shall be made available to Director under a
          joint defense agreement, so long as it would remain privileged. In
          addition, and subject to the same limitations as set forth in the two
          preceding sentences, the Company agrees (a) to provide Director and
          Director's authorized representatives with reasonable access to the
          books and records of the Company and its subsidiaries with respect to
          any such Action, (b) to cause its officers, employees, and advisors
          to furnish Director with such information to the extent that such
          information is necessary in connection with Director's evaluation or
          defense of any such Action, and (c) to notify and consult with
          Director and Director's authorized representatives before initiating
          any Action within the scope of this paragraph 3. The Company has
          designated the General Counsel of the Company as the point of contact
          for Director and Director's authorized representatives to seek the
          updates, documents, and other information contemplated by this
          paragraph. Director acknowledges and agrees that Director's sole
          remedy for any breach of this paragraph 3 shall be to seek specific
          performance of the Company's obligations hereunder, so long as the
          Company acts in good faith.

     4.   Insurance & Indemnification. In (i) resolving any coverage disputes
          by insurers with respect to currently existing directors' and
          officers' insurance policies that provide coverage for Actions that
          relate to actions or omissions prior to Director's voluntary
          resignation, (ii) seeking coverage under any currently existing
          directors' and officers' insurance policies with respect to any
          Action, or (iii) interpreting and applying the terms of the Indemnity
          Agreement, the Company shall not enter into agreements or support or
          take positions that disadvantage Director, or treat Director less
          favorably, as compared to any then current director, because Director
          is no longer a member of the Company's Board of Directors. Nothing
          contained herein is intended to prohibit or limit the application of
          any currently existing directors' and officers' insurance policy in
          accordance with its terms. For purposes of this paragraph 4, the term
          "currently existing directors' and officers' insurance policies" is
          intended to include within its scope all insurance policies of the
          Company obtained prior to May 10, 2005, including those that have
          purportedly been rescinded or otherwise challenged by the issuers
          thereof.

     5.   Cooperation. Director hereby agrees, subject to applicable
          attorney-client privileges and other applicable privileges, to
          cooperate in good faith with all reasonable requests by the Company
          in connection with any governmental investigation or defense or
          prosecution of any Action. The Company agrees to take due account of
          Director's regular employment and other business obligations in
          requesting Director to make personal appearances or travel and agrees
          to reimburse Director for reasonable out-of-pocket travel and similar
          expenses incurred by Director in response to the Company's requests.
          The Company acknowledges and agrees that the Company's sole remedy
          for any breach of this paragraph 5 shall be to seek specific
          performance of the Director's obligations hereunder, so long as
          Director acts in good faith.

     6.   Specific Performance. The Company and Director acknowledge and agree
          that the Company or Director, as the case may be, will be irreparably
          damaged if this agreement is not specifically enforced. Upon a breach
          or threatened breach of any provision of this agreement by the
          Company or Director, the other party to this agreement, shall, in
          addition to all other remedies, be entitled to seek specific
          performance.

     7.   Counterparts. This letter agreement may be executed in one or more
          counterparts. All such counterparts shall constitute one and the same
          agreement and shall become effective when one or more counterparts
          have been signed by each party and delivered to the other party.

     8.   Governing Law. This letter agreement shall be governed by, and
          construed and enforced in accordance with, the laws of the State of
          Delaware, applied without giving effect to any conflicts-of-law
          principles.

                  If the foregoing correctly and completely sets forth our
understanding, please sign the enclosed copy of this letter in the space
provided and return it to the Company.

                                      Very truly yours,

                                      HEALTHSOUTH CORPORATION


                                      By:  /s/ Gregory L. Doody
                                         -------------------------------
                                         Name: Gregory L. Doody
                                         Title:  Executive Vice President,
                                                 General Counsel and Secretary


Confirmed and agreed to as of the date first written above:
Joel C. Gordon

 /s/ Joel C. Gordon
-----------------------
[{"type": "8-K", "sequence": "1", "filename": "wil413641.txt", "description": "FORM 8-K", "secsgml_size_bytes": 14311}]
{"company-data": {"conformed-name": "HEALTHSOUTH CORP", "cik": "0000785161", "assigned-sic": "8093", "irs-number": "630860407", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-14940", "film-number": "05814830"}, "business-address": {"street1": "ONE HEALTHSOUTH PKWY", "street2": "STE 224W", "city": "BIRMINGHAM", "state": "AL", "zip": "35243", "phone": "2059677116"}, "mail-address": {"street1": "ONE HEALTHSOUTH PARKWAY", "city": "BIRMINGHAM", "state": "AL", "zip": "35243"}, "former-company": {"former-conformed-name": "HEALTHSOUTH REHABILITATION CORP", "date-changed": "19920703"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934

         Date of Report (date of earliest event reported): May 10, 2005

                            HEALTHSOUTH Corporation
             (Exact Name of Registrant as Specified in its Charter)

                                    Delaware
                 (State or Other Jurisdiction of Incorporation)

              1-10315                                  63-0860407
      (Commission File Number)              (IRS Employer Identification No.)

               One HEALTHSOUTH Parkway, Birmingham, Alabama 35243
          ------------------------------------------------------------
          (Address of Principal Executive Offices, Including Zip Code)

                                 (205) 967-7116
                                 --------------
              (Registrant's Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

[ ]   Written communications pursuant to Rule 425 under the Securities Act
      (17 CFR 230.425)

[ ]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
      CFR 240.14a-12)

[ ]   Pre-commencement communications pursuant to Rule 14d-2(b) under the
      Exchange Act (17 CFR 240.14d-2(b))

[ ]   Pre-commencement communications pursuant to Rule 13e-4(c) under the
      Exchange Act (17 CFR 240.13e-4(c))
ITEM 1.01   Entry into a Material Definitive Agreement

         As previously reported in its Current Report on Form 8-K filed with
the Securities and Exchange Commission on April 18, 2005, Joel C. Gordon
resigned, effective May 10, 2005, from the Board of Directors of HEALTHSOUTH
Corporation (the "Company"), where he served as Chairman Emeritus.

         In connection with Mr. Gordon's resignation, the Company entered into
a letter agreement with Mr. Gordon dated as of May 10, 2005 (the "Agreement"),
regarding certain matters relating to Mr. Gordon's retirement. The Agreement,
among other things, (a) acknowledges that Mr. Gordon's current indemnity
agreement remains in full force and effect following his resignation, (b) sets
forth the effect of Mr. Gordon's resignation on his outstanding stock options
and restricted stock grants and (c) provides that the Company will furnish
information to Mr. Gordon with respect to certain actions, suits, proceedings
or investigations involving the Company or any of its present or former
directors and that Mr. Gordon will cooperate in good faith with all reasonable
requests by the Company in connection with such actions, suits, proceedings or
investigations.

         The description of the Agreement contained herein is qualified in its
entirety by reference to the Agreement, a copy of which is attached hereto as
Exhibit 10 and incorporated herein by reference.

ITEM 9.01.  Financial Statements and Exhibits.

(c) Exhibits.

See Exhibit Index.
SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Current Report on Form 8-K to be signed on
its behalf by the undersigned hereunto duly authorized.

                                      HEALTHSOUTH CORPORATION

                                      By: /s/ Gregory L. Doody
                                         ------------------------------------
                                          Name:  Gregory L. Doody
                                          Title: Executive Vice President,
                                                 General Counsel and Secretary

Dated:  May 10, 2005
EXHIBIT INDEX

  Exhibit Number          Description
  --------------          -----------

      10                  Letter Agreement dated as of May 10, 2005, between
                          HEALTHSOUTH Corporation and Joel C. Gordon.
EXHIBIT 10

                           LETTERHEAD OF HEALTHSOUTH

                                  May 10, 2005

Joel C. Gordon
The Gordon Group
Suite 650
3102 West End Avenue
Nashville, TN  37203

Dear Joel:

         This is to confirm our agreement with respect to the matters set forth
below, all of which have been agreed to in connection with your retirement from
the Board of Directors of HealthSouth Corporation (the "Company").

     1.   Indemnity Agreement. Reference is made to that certain Indemnity
          Agreement ("Indemnity Agreement"), dated as of March 27, 2003, by and
          between you ("Director") and the Company. The Company hereby
          acknowledges, reaffirms and agrees that the Indemnity Agreement is
          and will continue to be in full force and effect, enforceable in
          accordance with the terms thereof, including after Director ceases to
          be a member of the Company's Board of Directors.

     2.   Equity Awards. Reference is made to that certain memorandum to Jay
          Grinney from Gregory L. Doody dated March 10, 2005 (the "Memorandum")
          regarding the effect of Director's retirement from the Board on the
          equity awards previously granted to Director by the Company. The
          Company hereby agrees that as set forth in the Memorandum by virtue
          of Director's retirement

          a.   all currently outstanding stock options (relating to 300,000
               shares with varying strike prices) would terminate within three
               months of Director's retirement in the event that they remain
               unexercised;

          b.   the restricted stock granted to Director on January 1, 2005
               (7,962 shares) would be forfeited; and

          c.   the remaining forfeiture provisions applicable to restricted
               stock granted to Director on January 20, 2004 and March 1, 2005
               shares (totaling 34,702 shares) would lapse.

     3.   Access to Information. The Company hereby agrees that, subject to
          appropriate confidentiality undertakings by Director, applicable
          attorney-client and other applicable privileges and to the extent not
          otherwise precluded by applicable law or contrary to a request of
          governmental authorities, at the request from time to time by
          Director or Director's authorized representative, the Company shall,
          and shall cause its General Counsel or his designees (or, if there is
          no General Counsel, by its Chief Financial Officer or his designees)
          to, furnish to Director or Director's authorized representatives
          updates and other requested information with respect to any actions,
          suits, or proceedings against, or any governmental investigations or
          negotiations with third parties involving, the Company or any of its
          present or former members of the Board of Directors, in each case
          only to the extent that such matter (i) arises from facts that took
          place prior to the date on which Director ceases to be a director of
          the Company and (ii) reasonably relates to the interests of Director
          (collectively, "Actions"). To the extent that any such requested
          information constitutes legal advice or other information subject to
          the attorney-client or related privilege, the Company shall provide
          such information to Director, so long as such information will
          continue to be subject to the attorney-client or other privilege (it
          being understood that the Company will enter into joint defense or
          other arrangements to protect the status of such information as
          privileged, if such arrangement would be effective to provide such
          protection), unless, (i) such information addresses a matter as to
          which the parties have a conflict of interests, or (ii) the Company
          has reasonably determined that providing such information will be
          materially prejudicial to the Company; provided that the immediately
          preceding clause (ii) shall not be a basis for denial of any Director
          request for privileged information if such information refers to
          Director or reflects Director's conduct or statements and, in such
          case, such information shall be made available to Director under a
          joint defense agreement, so long as it would remain privileged. In
          addition, and subject to the same limitations as set forth in the two
          preceding sentences, the Company agrees (a) to provide Director and
          Director's authorized representatives with reasonable access to the
          books and records of the Company and its subsidiaries with respect to
          any such Action, (b) to cause its officers, employees, and advisors
          to furnish Director with such information to the extent that such
          information is necessary in connection with Director's evaluation or
          defense of any such Action, and (c) to notify and consult with
          Director and Director's authorized representatives before initiating
          any Action within the scope of this paragraph 3. The Company has
          designated the General Counsel of the Company as the point of contact
          for Director and Director's authorized representatives to seek the
          updates, documents, and other information contemplated by this
          paragraph. Director acknowledges and agrees that Director's sole
          remedy for any breach of this paragraph 3 shall be to seek specific
          performance of the Company's obligations hereunder, so long as the
          Company acts in good faith.

     4.   Insurance & Indemnification. In (i) resolving any coverage disputes
          by insurers with respect to currently existing directors' and
          officers' insurance policies that provide coverage for Actions that
          relate to actions or omissions prior to Director's voluntary
          resignation, (ii) seeking coverage under any currently existing
          directors' and officers' insurance policies with respect to any
          Action, or (iii) interpreting and applying the terms of the Indemnity
          Agreement, the Company shall not enter into agreements or support or
          take positions that disadvantage Director, or treat Director less
          favorably, as compared to any then current director, because Director
          is no longer a member of the Company's Board of Directors. Nothing
          contained herein is intended to prohibit or limit the application of
          any currently existing directors' and officers' insurance policy in
          accordance with its terms. For purposes of this paragraph 4, the term
          "currently existing directors' and officers' insurance policies" is
          intended to include within its scope all insurance policies of the
          Company obtained prior to May 10, 2005, including those that have
          purportedly been rescinded or otherwise challenged by the issuers
          thereof.

     5.   Cooperation. Director hereby agrees, subject to applicable
          attorney-client privileges and other applicable privileges, to
          cooperate in good faith with all reasonable requests by the Company
          in connection with any governmental investigation or defense or
          prosecution of any Action. The Company agrees to take due account of
          Director's regular employment and other business obligations in
          requesting Director to make personal appearances or travel and agrees
          to reimburse Director for reasonable out-of-pocket travel and similar
          expenses incurred by Director in response to the Company's requests.
          The Company acknowledges and agrees that the Company's sole remedy
          for any breach of this paragraph 5 shall be to seek specific
          performance of the Director's obligations hereunder, so long as
          Director acts in good faith.

     6.   Specific Performance. The Company and Director acknowledge and agree
          that the Company or Director, as the case may be, will be irreparably
          damaged if this agreement is not specifically enforced. Upon a breach
          or threatened breach of any provision of this agreement by the
          Company or Director, the other party to this agreement, shall, in
          addition to all other remedies, be entitled to seek specific
          performance.

     7.   Counterparts. This letter agreement may be executed in one or more
          counterparts. All such counterparts shall constitute one and the same
          agreement and shall become effective when one or more counterparts
          have been signed by each party and delivered to the other party.

     8.   Governing Law. This letter agreement shall be governed by, and
          construed and enforced in accordance with, the laws of the State of
          Delaware, applied without giving effect to any conflicts-of-law
          principles.

                  If the foregoing correctly and completely sets forth our
understanding, please sign the enclosed copy of this letter in the space
provided and return it to the Company.

                                      Very truly yours,

                                      HEALTHSOUTH CORPORATION

                                      By:  /s/ Gregory L. Doody
                                         -------------------------------
                                         Name: Gregory L. Doody
                                         Title:  Executive Vice President,
                                                 General Counsel and Secretary

Confirmed and agreed to as of the date first written above:
Joel C. Gordon

 /s/ Joel C. Gordon
-----------------------